News

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...
People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...
The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...
A 5-day fasting-mimicking diet can help improve blood sugar control in type 2 diabetes, according to a recent clinical trial.
CHICAGO — Children exposed to gestational diabetes in utero have an altered hypothalamic response to glucose that leads to ...
Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...
Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.